CORTLAND, Ohio, Oct. 25, 2016 -- Cortland Bancorp (OTCQX:CLDB), the holding company for Cortland Savings and Banking Company, today announced that its Board of Directors declared a quarterly cash dividend of $0.07 per share. The dividend will be payable on December 1, 2016, to shareholders of record as of the close of business on November 10, 2016.
“We are pleased that our strong financial results have again allowed us to pay our quarterly cash dividend,” said James Gasior, President and Chief Executive Officer. “Our quarterly cash dividend reflects our continuing commitment to provide an attractive return to our shareholders.” At the stock price of $15.74 per share at the close of the market on October 21, 2016, the current dividend equates to a yield of 1.8% on an annualized basis.
Cortland Bancorp recently reported earnings of $1.2 million, or $0.27 per share, for the third quarter of 2016, unchanged from the third quarter of 2015. Year-to-date, earnings were $3.7 million, or $0.85 per share, versus $3.3 million, or $0.73 per share, for the first nine months of 2015, an increase of 13%.
About Cortland Bancorp
Cortland Bancorp is a financial holding company headquartered in Cortland, Ohio. Founded in 1892, the Company’s bank subsidiary, The Cortland Savings and Banking Company conducts business through thirteen full-service community banking offices located in the counties of Trumbull, Mahoning, Portage, and Ashtabula in Northeastern Ohio and two financial service centers in Beachwood and Fairlawn, Ohio. For additional information about Cortland Banks visit http://www.cortland-banks.com.
CONTACT: James M. Gasior, President & CEO (330) 282-4111 The Cereghino Group IR CONTACT: 206-388-5785


FDA Approves Mitapivat for Anemia in Thalassemia Patients
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Italy Fines Apple €98.6 Million Over App Store Dominance
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 



